Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Dufresne, A
1014  Ergebnisse:
Personensuche X
?
1

52O Resistance to imatinib induced by treatment interruptio..:

Blay, J-Y. ; Devin, Q. ; Duffaud, F....
ESMO Open.  9 (2024)  - p. 102442 , 2024
Link: https://doi.org/10.1016/..
 
?
2

59MO COTESARC – A multicentre, phase I-II clinical trial ev..:

Dufresne, A. ; Brahmi, M. ; Cropet, C....
ESMO Open.  9 (2024)  - p. 102449 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Improved nationwide survival of sarcoma patients with a net..:

Blay, J.Y. ; Penel, N. ; Valentin, T....
Annals of Oncology.  35 (2024)  4 - p. 351-363 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Corrigendum to "SELNET clinical practice guidelines for sof..:

Blay, J.Y. ; Hindi, N. ; Bollard, J....
Cancer Treatment Reviews.  115 (2023)  - p. 102523 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Natural history and treatment efficacy in an ambispective c..:

Dufresne, A. ; Pissaloux, D. ; Ngo, C....
ESMO Open.  8 (2023)  2 - p. 101202 , 2023
Link: https://doi.org/10.1016/..
 
?
6

66P Therapeutic opportunities in sarcomas and rare tumors: ..:

Vanacker, H. ; Brahmi, M. ; Cassier, P....
ESMO Open.  8 (2023)  1 - p. 101103 , 2023
Link: https://doi.org/10.1016/..
 
?
7

64P Tertiary lymphoid structure and efficacy of doxorubicin..:

Grassi, M. ; Dufresne, A. ; Karanian, M....
ESMO Open.  8 (2023)  1 - p. 101101 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nat..:

Blay, JY ; Piperno-Neumann, S. ; Watson, S....
European Journal of Cancer.  192 (2023)  - p. 113262 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Corrigendum to "SELNET clinical practice guidelines for bon..:

Blay, J.Y. ; Palmerini, E. ; Bollard, J....
Critical Reviews in Oncology/Hematology.  180 (2022)  - p. 103827 , 2022
Link: https://doi.org/10.1016/..
 
?
10

EE608 Cost Effectiveness Analysis of a Large (Foundation Me..:

Perrier, L ; Tredan, O ; Morelle, M...
Value in Health.  25 (2022)  12 - p. S175 , 2022
Link: https://doi.org/10.1016/..
 
?
11

SELNET clinical practice guidelines for bone sarcoma:

Blay, JY ; Palmerini, E. ; Bollard, J....
Critical Reviews in Oncology/Hematology.  174 (2022)  - p. 103685 , 2022
Link: https://doi.org/10.1016/..
 
?
12

SELNET clinical practice guidelines for soft tissue sarcoma..:

Blay, J.Y. ; Hindi, N. ; Bollard, J....
Cancer Treatment Reviews.  102 (2022)  - p. 102312 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Early phase trials in soft-tissue sarcomas: clinical benefi..:

Nassif, E.F. ; Blay, J.-Y. ; Massard, C....
ESMO Open.  7 (2022)  2 - p. 100425 , 2022
Link: https://doi.org/10.1016/..
 
?
14

A PHASE I TRIAL OF TARGETED IMMUNOTHERAPY WITH DARATUMUMAB ..:

Quigg, T. ; Flower, A. ; Teachey, D....
Leukemia Research.  121 (2022)  - p. S71-S73 , 2022
Link: https://doi.org/10.1016/..
 
?
15

P-020 PERFORMANCE OF AN ATRAUMATIC AND VERSATILE LIGHT-ACTI..:

Lopes, M ; Bitton, E ; Pereira, M..
British Journal of Surgery.  109 (2022)  Supplement_7 - p. , 2022
Link: https://doi.org/10.1093/..
 
1-15